Biolinq Safety and Effectiveness Trial
Public ClinicalTrials.gov record NCT06229743. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety and Effectiveness Study of the Biolinq MicroArray Intradermal Continuous Glucose Biowearable System
Study identification
- NCT ID
- NCT06229743
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Biolinq Inc.
- Industry
- Enrollment
- 247 participants
Conditions and interventions
Conditions
Interventions
- Biolinq System Device
Device
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2024
- Primary completion
- Jun 9, 2024
- Completion
- Jun 9, 2024
- Last update posted
- Jan 29, 2026
2024
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Metabolic Care + Research Institute | Escondido | California | 92025 | — |
| Diablo Clinical Research | Walnut Creek | California | 94598 | — |
| Atlanta Diabetes Associates | Atlanta | Georgia | 30318 | — |
| Rocky Mountain Clinical Research | Idaho Falls | Idaho | 83404 | — |
| Diabetes and Glandular Disease Clinic | San Antonio | Texas | 78229 | — |
| Rainier Clinical Research | Renton | Washington | 90857 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06229743, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 29, 2026 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06229743 live on ClinicalTrials.gov.